{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:55:39Z","timestamp":1787064939090,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"\u2018Agence Fran\u00e7aise de D\u00e9veloppement\u2019 through the AFROSCREEN project (grant agreement CZZ3209), coordinated by ANRS | Maladies infectieuses \u00e9mergentes in partnership with Institut Pasteur and IRD"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13029-8","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T19:16:09Z","timestamp":1773688569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genome characterization of the SARS-CoV-2 omicron in Cameroon"],"prefix":"10.1186","volume":"26","author":[{"given":"Chavely Gwladys","family":"Monamele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loique Landry Messanga","family":"Essengue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo\u00efse Henri","family":"Moumbeket-Yifomnjou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauliana Vanessa","family":"Ilouga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristide","family":"Mounchili-Njifon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Pascal","family":"Touoyem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle Madaha","family":"Longla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ripa Mohamadou","family":"Njankouo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdou Fatawou","family":"Modiyinji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifeanyi F.","family":"Omah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Njouom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"issue":"1","key":"13029_CR1","first-page":"3","volume":"28","author":"AJ Rodriguez-Morales","year":"2020","unstructured":"Rodriguez-Morales AJ, Bonilla-Aldana DK, Balbin-Ramon GJ, Rabaan AA, Sah R, Paniz-Mondolfi A, et al. History is repeating itself: Probable zoonotic spillover as the cause of the 2019 novel Coronavirus Epidemic. Infez Med. 1 mars 2020;28(1):3\u20135.","journal-title":"Infez Med 1 mars"},{"issue":"2","key":"13029_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3390\/pathogens9020148","volume":"9","author":"B Shanmugaraj","year":"2020","unstructured":"Shanmugaraj B, Malla A, Phoolcharoen W. Emergence of novel coronavirus 2019-nCoV: need for rapid vaccine and biologics development. Pathogens. 22 f\u00e9vr 2020;9(2):148.","journal-title":"Pathogens 22 f\u00e9vr"},{"issue":"8","key":"13029_CR3","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2217\/fvl-2020-0129","volume":"15","author":"A Bahrami","year":"2020","unstructured":"Bahrami A, Ferns GA. Genetic and pathogenic characterization of SARS-CoV-2: a review. Future Virol. ao\u00fbt 2020;15(8):533\u201349.","journal-title":"Future Virol ao\u00fbt"},{"key":"13029_CR4","first-page":"185","volume":"78","author":"M Nicola","year":"2020","unstructured":"Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Iosifidis C, et al. The socio-economic implications of the coronavirus pandemic (COVID-19): A review. Int J Surg Lond Engl. juin 2020;78:185\u201393.","journal-title":"Int J Surg Lond Engl juin"},{"key":"13029_CR5","doi-asserted-by":"publisher","first-page":"102433","DOI":"10.1016\/j.jaut.2020.102433","volume":"109","author":"HA Rothan","year":"2020","unstructured":"Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. mai 2020;109:102433.","journal-title":"J Autoimmun mai"},{"issue":"4","key":"13029_CR6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/0020764020915212","volume":"66","author":"J Torales","year":"2020","unstructured":"Torales J, O\u2019Higgins M, Castaldelli-Maia JM, Ventriglio A. The outbreak of COVID-19 coronavirus and its impact on global mental health. Int J Soc Psychiatry. juin 2020;66(4):317\u201320.","journal-title":"Int J Soc Psychiatry juin"},{"key":"13029_CR7","unstructured":"World Health Organization. Coronavirus Disease 2019 Dashboard [Internet]. [cit\u00e9 29 avr 2024]. Disponible sur: https:\/\/data.who.int\/dashboards\/covid19\/cases."},{"key":"13029_CR8","doi-asserted-by":"crossref","unstructured":"Lenharo M. WHO declares end to COVID-19\u2019s emergency phase. Nature. 2023. Available at: https:\/\/www.nature.com\/articles\/d41586-023-01559-z. Accessed 09 May 2023.","DOI":"10.1038\/d41586-023-01559-z"},{"key":"13029_CR9","unstructured":"Classification of Omicron (B.1.1.529). SARS-CoV-2 Variant of Concern [Internet]. [cit\u00e9 24 avr 2024]. Disponible sur: https:\/\/www.who.int\/news\/item\/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern"},{"issue":"3","key":"13029_CR10","first-page":"328","volume":"30","author":"A Ahmad","year":"2022","unstructured":"Ahmad A, Fawaz MAM, Aisha A. A comparative overview of SARS-CoV-2 and its variants of concern. Infez Med. 1 sept 2022;30(3):328\u201343.","journal-title":"Infez Med 1 sept"},{"issue":"4","key":"13029_CR11","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1002\/jmv.27467","volume":"94","author":"A Kumar","year":"2022","unstructured":"Kumar A, Parashar R, Kumar S, Faiq MA, Kumari C, Kulandhasamy M, et al. Emerging SARS-CoV-2 variants can potentially break set epidemiological barriers in COVID-19. J Med Virol. 2022;94(4):1300\u201314.","journal-title":"J Med Virol"},{"key":"13029_CR12","doi-asserted-by":"crossref","unstructured":"Wise J. Covid-19: New coronavirus variant is identified in UK. BMJ. 16 d\u00e9c. 2020;371:m4857.","DOI":"10.1136\/bmj.m4857"},{"issue":"7854","key":"13029_CR13","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41586-021-03402-9","volume":"592","author":"H Tegally","year":"2021","unstructured":"Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J, et al. Detection of a SARS-CoV-2 variant of concern in South Africa. Nat avr. 2021;592(7854):438\u201343.","journal-title":"Nat avr"},{"issue":"4","key":"13029_CR14","first-page":"1243","volume":"27","author":"T Fujino","year":"2021","unstructured":"Fujino T, Nomoto H, Kutsuna S, Ujiie M, Suzuki T, Sato R, et al. Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan. Emerg Infect Dis. avr 2021;27(4):1243\u20135.","journal-title":"Emerg Infect Dis avr"},{"issue":"7","key":"13029_CR15","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.3390\/microorganisms9071542","volume":"9","author":"S Cherian","year":"2021","unstructured":"Cherian S, Potdar V, Jadhav S, Yadav P, Gupta N, Das M, et al. SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India. Microorganisms. juill 2021;9(7):1542.","journal-title":"Microorganisms juill"},{"issue":"1","key":"13029_CR16","doi-asserted-by":"publisher","first-page":"21108","DOI":"10.1038\/s41598-021-00267-w","volume":"11","author":"W Wruck","year":"2021","unstructured":"Wruck W, Adjaye J. Detailed phylogenetic analysis tracks transmission of distinct SARS-COV-2 variants from China and Europe to West Africa. Sci Rep. 26 oct 2021;11(1):21108.","journal-title":"Sci Rep 26 oct"},{"key":"13029_CR17","doi-asserted-by":"crossref","unstructured":"Njouom R, Sadeuh-Mba SA, Tchatchueng J, Diagne MM, Dia N, Tagnouokam PAN, et al. Coding-complete genome sequence and phylogenetic relatedness of a SARS-CoV-2 strain detected in march 2020 in Cameroon. Microbiol Resour Announc. 11 mars 2021;10(10):e00093-21.","DOI":"10.1128\/MRA.00093-21"},{"key":"13029_CR18","unstructured":"WHO COVID-19. case definitions: updated in Public health surveillance for COVID-19, 22 July 2022 [Internet]. [cit\u00e9 3 sept 2025]. Disponible sur: https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Surveillance_Case_Definition-2022-1"},{"issue":"13","key":"13029_CR19","first-page":"30494","volume":"22","author":"Y Shu","year":"2017","unstructured":"Shu Y, McCauley J. Global initiative on sharing all influenza data \u2013 from vision to reality. Eurosurveillance. 30 mars 2017;22(13):30494.","journal-title":"Euro 30 mars"},{"key":"13029_CR20","unstructured":"Nextclade as pango lineage classifier. Methods and validation \u2014 nextclade documentation [Internet]. [cit\u00e9 6 mai 2024]. Disponible sur: https:\/\/docs.nextstrain.org\/projects\/nextclade\/en\/stable\/user\/algorithm\/nextclade-pango.html"},{"key":"13029_CR21","doi-asserted-by":"crossref","unstructured":"Aksamentov I, Roemer C, Hodcroft EB, Neher RA. Nextclade: clade assignment, mutation calling and quality control for viral genomes. J Open Source Softw. 30 Nov 2021;30(67):3773.","DOI":"10.21105\/joss.03773"},{"issue":"23","key":"13029_CR22","first-page":"4121","volume":"34","author":"J Hadfield","year":"2018","unstructured":"Hadfield J, Megill C, Bell SM, Huddleston J, Potter B, Callender C, et al. Nextstrain: real-time tracking of pathogen evolution. Bioinf. 22 May 2018;34(23):4121\u20133.","journal-title":"Bioinf 22 May"},{"key":"13029_CR23","doi-asserted-by":"crossref","unstructured":"Majed SO, Mustafa SA, Jalal PJ, Fatah MH, Miasko M, Jawhar Z, et al. SARS-CoV-2 omicron variant genomic and phylogenetic analysis in Iraqi Kurdistan region. Genes. 9 janv 2023;14(1):173.","DOI":"10.3390\/genes14010173"},{"issue":"7902","key":"13029_CR24","first-page":"679","volume":"603","author":"R Viana","year":"2022","unstructured":"Viana R, Moyo S, Amoako DG, Tegally H, Scheepers C, Althaus CL, et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature. mars 2022;603(7902):679\u201386.","journal-title":"Nat mars"},{"issue":"9","key":"13029_CR25","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1038\/s41591-022-01911-2","volume":"28","author":"H Tegally","year":"2022","unstructured":"Tegally H, Moir M, Everatt J, Giovanetti M, Scheepers C, Wilkinson E, et al. Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa. Nat Med. sept 2022;28(9):1785\u201390.","journal-title":"Nat Med sept"},{"issue":"1","key":"13029_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41392-023-01391-x","volume":"8","author":"A Zhu","year":"2023","unstructured":"Zhu A, Wei P, Man M, Liu X, Ji T, Chen J, et al. Antigenic characterization of SARS-CoV-2 Omicron subvariants XBB.1.5, BQ.1, BQ.1.1, BF.7 and BA.2.75.2. Signal Transduct Target Ther. 15 mars 2023;8(1):125.","journal-title":"Signal Transduct Target Ther 15 mars"},{"issue":"2","key":"13029_CR27","doi-asserted-by":"publisher","first-page":"e239","DOI":"10.1002\/mco2.239","volume":"4","author":"D Ao","year":"2023","unstructured":"Ao D, He X, Hong W, Wei X. The rapid rise of SARS-CoV-2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants. MedComm. avr 2023;4(2):e239.","journal-title":"MedComm avr"},{"key":"13029_CR28","doi-asserted-by":"crossref","unstructured":"Jony MHK, Alam AN, Nasif MAO, Sultana S, Anwar R, Rudra M, et al. Emergence of SARS-CoV-2 Omicron sub-lineage JN.1 in Bangladesh. Microbiol Resour Announc. 13(6):e00130\u201324.","DOI":"10.1128\/mra.00130-24"},{"key":"13029_CR29","doi-asserted-by":"crossref","unstructured":"Torres C, Nabaes Jodar M, Acu\u00f1a D, Monta\u00f1o RMZ, Culasso ACA, Amadio AF, et al. Omicron waves in Argentina: dynamics of SARS-CoV-2 lineages BA.1, BA.2 and the emerging BA.2.12.1 and BA.4\/BA.5. Viruses. 22 janv 2023;15(2):312.","DOI":"10.3390\/v15020312"},{"issue":"1","key":"13029_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jobb.2023.01.002","volume":"5","author":"Y Sun","year":"2023","unstructured":"Sun Y, Wang M, Lin W, Dong W, Xu J. Evolutionary analysis of Omicron variant BF.7 and BA.5.2 pandemic in China. J Biosaf Biosecur. mars 2023;5(1):14\u201320.","journal-title":"J Biosaf Biosecur mars"},{"key":"13029_CR31","first-page":"9769586","volume":"2021","author":"Q Yang","year":"2021","unstructured":"Yang Q, Syed AAS, Fahira A, Shi Y. Structural analysis of the SARS-CoV-2 Omicron variant proteins. Res Wash DC. 2021;2021:9769586.","journal-title":"Res Wash DC"},{"issue":"10","key":"13029_CR32","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1002\/jmv.27927","volume":"94","author":"S Kumar","year":"2022","unstructured":"Kumar S, Karuppanan K, Subramaniam G. Omicron (BA.1) and sub-variants (BA.1.1, BA.2, and BA.3) of SARS-CoV-2 spike infectivity and pathogenicity: A comparative sequence and structural-based computational assessment. J Med Virol. oct 2022;94(10):4780\u201391.","journal-title":"J Med Virol oct"},{"key":"13029_CR33","doi-asserted-by":"publisher","unstructured":"Abbas Q, Kusakin A, Sharrouf K, Jyakhwo S, Komissarov AS. Follow-up investigation and detailed mutational characterization of the SARS-CoV-2 Omicron variant lineages (BA.1, BA.2, BA.3 and BA.1.1) [Internet]. bioRxiv; 2022 [cit\u00e9 3 sept 2025]. p. 2022.02.25.481941. Disponible sur: https:\/\/www.biorxiv.org\/content\/https:\/\/doi.org\/10.1101\/2022.02.25.481941v1","DOI":"10.1101\/2022.02.25.481941v1"},{"issue":"12","key":"13029_CR34","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1016\/S1473-3099(22)00694-6","volume":"22","author":"Q Wang","year":"2022","unstructured":"Wang Q, Li Z, Ho J, Guo Y, Yeh AY, Mohri H, et al. Resistance of SARS-CoV-2 omicron subvariant BA.4.6 to antibody neutralisation. Lancet Infect Dis d\u00e9c. 2022;22(12):1666\u20138.","journal-title":"Lancet Infect Dis d\u00e9c"},{"issue":"7898","key":"13029_CR35","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","volume":"602","author":"Y Cao","year":"2022","unstructured":"Cao Y, Wang J, Jian F, Xiao T, Song W, Yisimayi A, et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature. f\u00e9vr 2022;602(7898):657\u201363.","journal-title":"Nat f\u00e9vr"},{"issue":"6","key":"13029_CR36","doi-asserted-by":"publisher","first-page":"e0325133","DOI":"10.1371\/journal.pone.0325133","volume":"20","author":"E Mbogori","year":"2025","unstructured":"Mbogori E, Thiongo K, Deng HY, Gikunyu CW, Cheriro W, Musyoki S, et al. SARS-COV-2 mutations in North Rift, Kenya. PLoS ONE. 2025;20(6):e0325133.","journal-title":"PLoS ONE"},{"issue":"9","key":"13029_CR37","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/s41564-021-00954-4","volume":"6","author":"J Zahradn\u00edk","year":"2021","unstructured":"Zahradn\u00edk J, Marciano S, Shemesh M, Zoler E, Harari D, Chiaravalli J, et al. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution. Nat Microbiol. sept 2021;6(9):1188\u201398.","journal-title":"Nat Microbiol sept"},{"issue":"2","key":"13029_CR38","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3201\/eid2802.212422","volume":"28","author":"H Gu","year":"2022","unstructured":"Gu H, Krishnan P, Ng DYM, Chang LDJ, Liu GYZ, Cheng SSM, et al. Probable Transmission of SARS-CoV-2 Omicron Variant in Quarantine Hotel, Hong Kong, China, November 2021. Emerg Infect Dis. f\u00e9vr 2022;28(2):460\u20132.","journal-title":"Emerg Infect Dis f\u00e9vr"},{"key":"13029_CR39","doi-asserted-by":"publisher","first-page":"708264","DOI":"10.3389\/fimmu.2021.708264","volume":"12","author":"N Redondo","year":"2021","unstructured":"Redondo N, Zald\u00edvar-L\u00f3pez S, Garrido JJ, Montoya M. SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns. Front Immunol. 2021;12:708264.","journal-title":"Front Immunol"},{"issue":"2","key":"13029_CR40","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s11427-021-1964-4","volume":"65","author":"C Bai","year":"2022","unstructured":"Bai C, Zhong Q, Gao GF. Overview of SARS-CoV-2 genome-encoded proteins. Sci China Life Sci. f\u00e9vr 2022;65(2):280\u201394.","journal-title":"Sci China Life Sci f\u00e9vr"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13029-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13029-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13029-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:56:00Z","timestamp":1776923760000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13029-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13029"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13029-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the National Ethics Committee for Human Health Research (Comit\u00e9 National d\u2019Ethique pour la Recherche en Sant\u00e9 Humaine, CNERSH) under the approval number: N\u00ba 2020\/05\/1224\/CE\/CNERSH\/SP. Written informed consent was obtained from all participants or their guardians: directly from participants aged 21 and above, and from the parents or legal guardians of minors. The study was conducted following the principles of the Declaration of Helsinki and Good Clinical Practice guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"820"}}